The Interventional Glaucoma Podcast

Bausch + Lomb Elios
  • 0.0 (0)
  • MEDICINE
  • MONTHLY

Join global thought leaders as they engage in unscripted discussions about the latest innovations in Interventional Glaucoma; an inspiring and thought-provoking mindset that prioritizes patient-centered care and challenges ophthalmologists to rethink their treatment strategies. Brought to you by Bausch + Lomb Elios.

  1. 3 DEC

    Health Economics in Interventional Glaucoma

    In this episode of the Interventional Glaucoma Podcast, Prof. Gus Gazzard speaks with Dr. Marc Töteberg-Harms and Dr. Timothy Hamann about the health economics of interventional glaucoma. They discuss how MIGS can deliver long-term savings and quality-of-life benefits despite higher upfront costs, highlight evidence supporting its cost-effectiveness, and emphasize the growing ethical responsibility for clinicians to discuss MIGS options with eligible cataract patients.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.  ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.  Find out more about ELIOS : http://bit.ly/4lWBJZ1

    36 min

  2. 19 NOV

    Excimer fundamentals

    In this episode of the Interventional Glaucoma podcast, Prof. Gus Gazzard speaks with Dr. Neeru Vallabh and Mr. Dirk Mühlhoff about how excimer laser technology is transforming glaucoma treatment. They discuss Excimer Laser Trabeculostomy (ELT), which uses ultraviolet light to create precise, non-thermal microchannels in the trabecular meshwork, improving natural fluid outflow. The conversation highlights how this laser, long used in refractive surgery, is now offering a safe, minimally invasive option for glaucoma patients.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.  ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.  Find out more about ELIOS : http://bit.ly/4lWBJZ1

    25 min

  3. 17 JUL

    Integrating Glaucoma into your standard Phaco routine

    In this episode of the Interventional Glaucoma Podcast, Prof. Verena Prokosch and Ms. Nishani Amerasinghe discuss the integration of minimally invasive glaucoma surgery (MIGS) into routine cataract surgery. They focus on how laser-based trabecular procedures can be efficiently combined with phacoemulsification to improve outcomes for glaucoma patients.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.  ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.  Find out more about ELIOS : http://bit.ly/4lWBJZ1

    24 min

  4. 25 JUN

    Are patients really happier after Glaucoma surgery?

    In this episode, host Gok Ratnarajan is joined by Dr. Ana Miguel, Dr. Karl Mercieca, and Dr. Jose Belda to explore whether patients truly experience greater happiness following glaucoma surgery. Through anonymized case studies and real-world examples, the panel delves into how an interventional glaucoma approach can impact patient quality of life. Together, they reflect on patient expectations and outcomes, sharing personal experiences to provide a balanced and insightful discussion on the patient perspective in glaucoma care.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.  ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.

    40 min

  5. 5 MAY

    Managing Expectations: What really matters to patients

    In this episode, Professor Ike Ahmed welcomes Dr. Ticiana de Francesco, Dr. Nathan Radcliffe, and Dr. Mark Gallardo to discuss goal setting in interventional glaucoma care. They emphasize the importance of aligning treatment strategies with patient expectations, focusing on disease control while aiming to reduce or eliminate medication use.  They introduce a practical tool to support goal setting, which can be downloaded at https://eliosvision.com/ous/resources/.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

    22 min

  6. 31 MAR

    ELIOS - What I learned from my first 100 cases - Part 2

    In this second episode of a special two-part series on the Interventional Glaucoma Podcast, host Gok Ratnarajan is joined by Anselm Juenemann, Dan Lindfield, Jose Belda, and Nils Loewen to share insights from their first 100 ELIOS cases. They discuss patient selection, technique, and post-op management, while also exploring strategies to reduce the learning curve.  The conversation covers the safety and efficacy of ELIOS, and how to manage medications post-op for the best outcomes. The experts highlight the importance of clinical experience in achieving reliable results and provide valuable tips for glaucoma surgeons.

    12 min

  7. 24 MAR

    ELIOS - What I learned from my first 100 cases - Part 1

    In this first episode of the special two-episode series of the Interventional Glaucoma podcast, host Gok Ratnarajan is joined by esteemed guests Anselm Juenemann, Dan Lindfield, Jose Belda, and Nils Loewen to discuss key insights from their first 100 Elios cases. They share expert tips on technique, patient selection, and post-op management while exploring strategies to reduce the Elios learning curve. The conversation also delves into the safety and efficacy of the procedure and its impact on patient quality of life.

    30 min

  8. 27 JAN

    Captivating Cases: Reviewed by Prof Ike Ahmed

    In this episode of the Interventional Glaucoma podcast, Prof. Ike Ahmed presents a series of ELIOS case studies recorded by Dr. Ana Miguel, Dr. Jose Belda, Dr. Karl Mercieca, and Ms. Nishani Amerasinghe. The cases explore the versatility of the ELIOS procedure in managing glaucoma, from early intervention in ocular hypertension to addressing complex cases with prior MIGS treatments.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

    29 min
See All (19)

About

Join global thought leaders as they engage in unscripted discussions about the latest innovations in Interventional Glaucoma; an inspiring and thought-provoking mindset that prioritizes patient-centered care and challenges ophthalmologists to rethink their treatment strategies. Brought to you by Bausch + Lomb Elios.

Information

You Might Also Like